Japan's conditional early approval program for innovative cancer drugs: Comparison of the regulatory processes with the US FDA and the EMA.
作者信息
Murayama Anju, Ueda Munetaka, Shrestha Sunil, Tanimoto Tetsuya, Ozaki Akihiko
机构信息
Medical Governance Research Institute, Minato-ku, Tokyo, Japan; Tohoku University School of Medicine, Sendai, Miyagi, Japan.
Medical Governance Research Institute, Minato-ku, Tokyo, Japan; Department of Orthopedic Surgery, Yokohama Rosai Hospital, Yokohama-shi, Kanagawa, Japan.
出版信息
Cancer Cell. 2021 Sep 13;39(9):1165-1166. doi: 10.1016/j.ccell.2021.07.008. Epub 2021 Aug 5.
PMID:34358449
Abstract
摘要
Zotero 插件